Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q2 2026)
1,270,531
Value
$47.5M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of CRNX by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,270,531$47.5M<0.1%+418,273+49.1%AddedHolders
Q1 2026852,258$30.9M<0.1%+303,281+55.2%AddedHolders
Q4 2025548,977$25.6M<0.1%+171,175+45.3%AddedHolders
Q3 2025377,802$15.7M<0.1%+202,545+115.6%AddedHolders
Q2 2025175,257$5.04M<0.1%+155,534+788.6%AddedHolders
Q1 202519,723$661.5K<0.1%+19,723NewHolders
Q4 20240$00.0%−392,196−100.0%Sold outHolders
Q3 2024392,196$20.0M<0.1%−154,563−28.3%ReducedHolders
Q2 2024546,759$24.5M<0.1%−94,043−14.7%ReducedHolders
Q1 2024640,802$30.0M<0.1%−19,119−2.9%ReducedHolders
Q4 2023659,921$23.5M<0.1%−84,895−11.4%ReducedHolders
Q3 2023744,816$22.2M<0.1%+225,707+43.5%AddedHolders
Q2 2023519,109$9.35M<0.1%+69,504+15.5%AddedHolders
Q1 2023449,605$7.22M<0.1%−59,243−11.6%ReducedHolders
Q4 2022508,848$9.31M<0.1%−27,222−5.1%ReducedHolders
Q3 2022536,070$10.5M<0.1%−17,801−3.2%ReducedHolders
Q2 2022553,871$10.3M<0.1%+64,514+13.2%AddedHolders
Q1 2022489,357$10.7M<0.1%+143,913+41.7%AddedHolders
Q4 2021345,444$9.81M<0.1%+34,100+11.0%AddedHolders
Q3 2021311,344$6.55M<0.1%+126,051+68.0%AddedHolders
Q2 2021185,293$3.49M<0.1%+119,573+181.9%AddedHolders
Q1 202165,720$1.00M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.